0001601830-16-000006.txt : 20160914 0001601830-16-000006.hdr.sgml : 20160914 20160914160820 ACCESSION NUMBER: 0001601830-16-000006 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160914 DATE AS OF CHANGE: 20160914 EFFECTIVENESS DATE: 20160914 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RECURSION PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001601830 IRS NUMBER: 464099738 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-270639 FILM NUMBER: 161885188 BUSINESS ADDRESS: STREET 1: 383 S. COLOROW DR CITY: SALT LAKE CITY STATE: UT ZIP: 84108 BUSINESS PHONE: 801-587-1629 MAIL ADDRESS: STREET 1: 383 S. COLOROW DR CITY: SALT LAKE CITY STATE: UT ZIP: 84108 FORMER COMPANY: FORMER CONFORMED NAME: Recursion Pharmaceuticals, LLC DATE OF NAME CHANGE: 20140305 D 1 primary_doc.xml X0707 D LIVE 0001601830 RECURSION PHARMACEUTICALS, INC. 383 S. COLOROW DR SALT LAKE CITY UT UTAH 84108 801-587-1629 DELAWARE Recursion Pharmaceuticals, LLC Corporation true 2013 CHRISTOPHER C. GIBSON 383 S. COLOROW DR Salt Lake City UT UTAH 84108 Executive Officer Director Promoter DEAN Y. LI 383 S. COLOROW DR Salt Lake City UT UTAH 84108 Executive Officer Director Promoter Dr. Li ceased to be a director upon conversion of the LLC to a corporation. BLAKE C. BORGESON 383 S. COLOROW DR Salt Lake City UT UTAH 84108 Executive Officer Director Promoter H. PERRY FELL 383 S. COLOROW DR SALT LAKE CITY UT UTAH 84108 Director ZAVAIN DAR 1600 EL CAMINO REAL SUITE 290 MENLO PARK CA CALIFORNIA 94025 Director Mr. Dar became a director on September 2, 2016. REID HUTCHINS 5 WARREN STREET GLENN FALLS NY NEW YORK 12801 Director Mr. Hutchins became a director on September 2, 2016. Pharmaceuticals Decline to Disclose 06b false 2016-09-01 false true true The offering is being made in connection with the issuer's conversion from a Delaware LLC to a Delaware corporation. 0 32000000 32000000 0 Reflects the issuance of shares by the corporation in connection with the conversion of the LLC to a corporation. false 32 0 0 0 false RECURSION PHARMACEUTICALS, INC. /s/ Christopher C. Gibson Christopher C. Gibson Chief Executive Officer 2016-09-14